U.S. BioDefense Cordially Invited by Canadian Consulate to Attend the Internationalizing Early-Stage Clinical Drug Research & Development Conference
18. Februar 2005 07:00 ET
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Feb. 18, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTCBB:UBDE) announces that they will be attending the Internationalizing Early-Stage Clinical Drug Research & Development...
U.S. BioDefense Retains Shannon Eaker, Ph.D. as a Consultant for Stem Cell Center of Excellence RFA Response
16. Februar 2005 09:30 ET
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Feb. 16, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTCBB:UBDE) is pleased to announce today that the company has retained the consulting services of Shannon S. Eaker,...
U.S. BioDefense Plans Response for Funding and Building 'Center of Excellence in Stem Cell Research' a $4.5 Million National Institutes of Health RFA
11. Februar 2005 14:12 ET
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Feb. 11, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTCBB:UBDE) CEO David Chin is pleased to announce today that the company will file a Letter of Intent for Grant Funding...
U.S. BioDefense Signs Agreement with NYSE Listed $4 Billion Biomedical Company
08. Februar 2005 11:07 ET
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Feb. 8, 2005 (PRIMEZONE) -- U.S. BioDefense (OTCBB:UBDE) is pleased to announce today that it has signed a secrecy agreement with the office of technology transfer at a NYSE...
U.S. BioDefense to Advertise on CNBC Next Week to Build Awareness of its California Stem Cell Technology Transfer Initiative
04. Februar 2005 09:00 ET
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Feb. 4, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTCBB:UBDE), a Department of Defense central contractor that researches, develops, and commercializes leading-edge...
U.S. BioDefense Now Trading Under Stock Symbol UBDE
03. Februar 2005 10:20 ET
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Feb. 3, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTCBB:UBDE), a Department of Defense central contractor that researches, develops, and commercializes leading-edge...
U.S. BioDefense Forward Stock Split Effective on Market Open Tomorrow Under New Stock Symbol UBDE
02. Februar 2005 14:51 ET
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Feb. 2, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTCBB:UBDF) is pleased to announce today that it has been informed by the NASD that its three for one forward stock split...
U.S. BioDefense, Inc. Publishes White Paper: 'Collaborative Stem Cell Technology Commercialization Opportunities in California'
01. Februar 2005 15:44 ET
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Feb. 1, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTCBB:UBDF) is pleased to announce today that it has released its White Paper at usbiodefense.com entitled "Collaborative...
U.S. BioDefense Extends Forward Stock Split Effective Date and Identifies New $4.5 Million National Institutes of Health SBIR Grant
01. Februar 2005 11:34 ET
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Feb. 1, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTCBB:UBDF) CEO David Chin is pleased to announce that the company's forward stock split is on track, but has been briefly...
U.S. BioDefense, Inc. Applies for International Society for Stem Cell Research Membership
28. Januar 2005 08:45 ET
|
U.S. BioDefense
CITY OF INDUSTRY, Calif., Jan. 28, 2005 (PRIMEZONE) -- U.S. BioDefense, Inc. (OTCBB:UBDF) CEO David Chin is pleased to announce today that the company has submitted its application for membership in...